Cargando…

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease

INTRODUCTION: Kawasaki disease is a kind of systemic vasculitis that mainly damages moderate and small-sized blood vessels, and is a leading cause of coronary artery lesions (CAL). Antiplatelet therapy is a routine component of Kawasaki disease treatment strategies. So it is important to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pi, Lei, Che, Di, Long, Haifeng, Fang, Zhenzhen, Li, Jiawen, Lin, Shuyi, Liu, Yunfeng, Li, Meiai, Bao, Lijuan, Li, Wenli, Zhang, Yuan, Deng, Qiulian, Liu, Techang, Zhang, Li, Gu, Xiaoqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973383/ https://www.ncbi.nlm.nih.gov/pubmed/29872260 http://dx.doi.org/10.2147/DDDT.S163705

Ejemplares similares

Lack of association between miR-218 rs11134527 A>G and Kawasaki disease susceptibility
por: Pi, Lei, et al.
Publicado: (2018)

Integrin α2 gene polymorphism is a risk factor of coronary artery lesions in Chinese children with Kawasaki disease
por: Yuan, Jia, et al.
Publicado: (2021)

The IL-1B Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease
por: Fu, Lan Yan, et al.
Publicado: (2019)

An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease
por: Liu, Yunfeng, et al.
Publicado: (2019)

ABCC4 Variants Modify Susceptibility to Kawasaki Disease in a Southern Chinese Population
por: Che, Di, et al.
Publicado: (2018)

Gene Polymorphism of Aspirin-Induced Urticaria in Children With Kawasaki Disease
por: Zhang, Hui, et al.
Publicado: (2019)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Impact of Platelet Glycoprotein Ia/IIa C807T Gene Polymorphisms on Coronary Artery Aneurysms of KD Patients
por: Li, Wei, et al.
Publicado: (2021)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Immature platelet fraction in cardiovascular diagnostics and antiplatelet therapy monitoring
por: Gumiężna, Karolina, et al.
Publicado: (2023)

The rs1625579 T>G polymorphism in the miRNA-13 gene confers a risk of early- onset Kawasaki disease in a southern Chinese population
por: Che, Di, et al.
Publicado: (2018)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Effect of different doses of aspirin on the prognosis of Kawasaki disease
por: Wang, Jinxin, et al.
Publicado: (2020)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Aspirin-Induced Delayed Urticaria in Children with Kawasaki Disease: A Retrospective Case-Control Study
por: Lin, Yao, et al.
Publicado: (2021)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

The association between the miR-146a rs2910164 C>G polymorphism and Kawasaki disease in a southern Chinese population
por: Zhang, Li, et al.
Publicado: (2018)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Association study of miR‐149, miR‐196a2, and miR‐499a polymorphisms with coronary artery aneurysm of Kawasaki disease in southern Chinese population
por: Fu, Lanyan, et al.
Publicado: (2022)

Exploring the Mechanism of Aspirin in the Treatment of Kawasaki Disease Based on Molecular Docking and Molecular Dynamics
por: Xiong, Li, et al.
Publicado: (2022)

Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?
por: Lee, Goni, et al.
Publicado: (2013)

Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial
por: Li, Dan, et al.
Publicado: (2021)

The EIF2AK4/rs4594236 AG/GG Genotype Is a Hazard Factor of Immunoglobulin Therapy Resistance in Southern Chinese Kawasaki Disease Patients
por: Yu, Hongyan, et al.
Publicado: (2022)

Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
por: Sawardekar, Swapna B., et al.
Publicado: (2016)

The miRNA-608 rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population
por: Wang, Yanfei, et al.
Publicado: (2019)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Platelet function-guided modification in antiplatelet therapy after acute ischemic stroke is associated with clinical outcomes in patients with aspirin nonresponse
por: Yi, Xingyang, et al.
Publicado: (2017)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Protective Effect of TNFRSF11A rs7239667 G > C Gene Polymorphism on Coronary Outcome of Kawasaki Disease in Southern Chinese Population
por: Zhang, Linyuan, et al.
Publicado: (2021)

FNDC1 Polymorphism (rs3003174 C > T) Increased the Incidence of Coronary Artery Aneurysm in Patients with Kawasaki Disease in a Southern Chinese Population
por: Lin, Kun, et al.
Publicado: (2021)

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Analysis of Gastrointestinal Prophylaxis in Patients Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Morneau, Kathleen M., et al.
Publicado: (2014)

The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury
por: Gao, Lichao, et al.
Publicado: (2023)

Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2019)

Association between Rab31/rs9965664 polymorphism and immunoglobulin therapy resistance in patients with Kawasaki disease
por: Yu, Hongyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1pg6e70qhso37p119jrs2o2oec